Bryan Jacobs
Director of Finance/CFO at CIPHER PHARMACEUTICALS INC.
Net worth: 32 955 $ as of 2024-03-30
Profile
Bryan Jacobs is currently the Chief Financial Officer & Secretary at Cipher Pharmaceuticals, Inc. Prior to this role, he served as the Controller at Advanz Pharma Corp.
Ltd.
and as the Chief Financial Officer at AXYZ Automation, Inc. Mr. Jacobs completed his undergraduate degree at McMaster University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-03-19 | 5,000 ( 0.02% ) | 32 955 $ | 2024-03-30 |
Bryan Jacobs active positions
| Companies | Position | Start |
|---|---|---|
| CIPHER PHARMACEUTICALS INC. | Director of Finance/CFO | 2022-08-14 |
Former positions of Bryan Jacobs
| Companies | Position | End |
|---|---|---|
AXYZ Automation, Inc.
 AXYZ Automation, Inc. Industrial MachineryProducer Manufacturing Part of AXYZ International, Inc., AXYZ Automation, Inc. manufactures industrial computer numerical control router and knife systems. The private company is located in Canada. | Director of Finance/CFO | 2022-07-31 |
| ADVANZ PHARMA CORP. LIMITED | Comptroller/Controller/Auditor | - |
Training of Bryan Jacobs
| McMaster University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| CIPHER PHARMACEUTICALS INC. | Health Technology |
| Private companies | 2 |
|---|---|
AXYZ Automation, Inc.
AXYZ Automation, Inc. Industrial MachineryProducer Manufacturing Part of AXYZ International, Inc., AXYZ Automation, Inc. manufactures industrial computer numerical control router and knife systems. The private company is located in Canada. | Producer Manufacturing |
Advanz Pharma Corp. Ltd.
 Advanz Pharma Corp. Ltd. Pharmaceuticals: MajorHealth Technology ADVANZ PHARMA Corp. Ltd. is a pharmaceutical company engages in the provision of branded and unbranded products. The firm specializes in anti-Infectives and endocrinology therapy areas. It operates through the following segments: Advanz Pharma International; Advanz Pharma North America; and Corporate. The Advanz Pharma International segment include portfolio of branded and generic products that are sold to wholesalers, hospitals, and pharmacies. The Advanz Pharma North America segment comprises branded products and authorized generic contracts that focuses primarily on the U.S. pharmaceutical market. The Corporate segment represents the centralized costs. The company was founded by Mark L. Thompson on January 20, 2010 and is headquartered in St. Helier, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Bryan Jacobs
